Results 231 to 240 of about 252,911 (302)

Prostaglandin E1 improves necrobiosis lipoidica.

Acta Dermato-Venereologica, 1995
C Kuwert, D Abeck, V Steinkraus, T Jakob, J Ring   +4 more
openaire   +1 more source

Prostaglandin E1 and fever.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1975
openaire   +1 more source

Therapeutic effect of prostaglandin E1 in monocrotaline-induced pulmonary arterial hypertension rats.

Anat Cell Biol, 2017
Lee JC.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines?

Cardiology in the Young, 2020
Introduction: Prostaglandin E1 is used to maintain ductal patency in critical congenital heart disease (CHD). The standard starting dose of prostaglandin E1 is 0.05 µg/kg/minute.
Daniel Vari, Wendi Xiao, S. Behere, E. Spurrier, T. Tsuda, J. Baffa   +5 more
semanticscholar   +1 more source

Fluorescence of prostaglandin E1

Analytical Chemistry, 1968
The chemical structure of PGE1 (prostaglandin E1) is diagrammed. Because this structure suggested the possibility of several resonance forms of the molecule a study was undertaken to determine their possible fluorescence. The laboratory procedures involved are explained. Increased concentrations of PGE1 were found to produce increased fluorescence.
C L, Gantt, L R, Kizlaitis, D R, Thomas, J G, Greslin   +3 more
openaire   +2 more sources

Misoprostol: A prostaglandin E1 analogue

American Journal of Health-System Pharmacy, 1989
The pharmacology, pharmacokinetics, clinical efficacy, contraindications and precautions, adverse effects, dosage, and cost of misoprostol are reviewed. Misoprostol is a synthetic analogue of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion and enhances mucosal resistance to injury.
R E, Garris, C F, Kirkwood
openaire   +2 more sources

Prostaglandin E1 in hand angiography

American Journal of Roentgenology, 1983
Prostaglandin E1 (PGE1) is a rapid, potent vasodilator which, when infused into the arterial system in low doses by bolus injection, has no significant systemic effects and has a relatively long duration of action. Sixty-three hand angiograms were done on 55 patients, comparing PGE1 to tolazoline and to angiograms done with no vasodilation.
J M, Levy, R B, Joseph, L S, Bodell, P W, Nykamp, S J, Hessel   +4 more
openaire   +2 more sources